Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol

Arzneimittel-Forschung/Drug Research

Volumn 46, Issue 8, 1996, Pages 766-773

  Setnikar, Ivo ^a   Rovati, Lucio C ^a   Vens Cappell, Bernard ^b   Hilgenstock, Christian ^b  

^a Rotta Research Laboratorium   (Italy)

^b Mc Knight Laboratories GmbH   (Germany)

Author keywords

CAS 50 28 2; CAS 53 16 7; Dermestril , clinical pharmacokinetics, estradiol and estrone concentrations; estradiol; estrogen replacement therapy, postmenopausal; estrone

Indexed keywords

ESTRADIOL; ESTRONE;

ABDOMINAL PAIN; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; ESTROGEN METABOLISM; FEMALE; HEADACHE; HOT FLUSH; HUMAN; HUMAN EXPERIMENT; MASTALGIA; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACEUTICS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; STEADY STATE; TABLET; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; AGED; DELAYED-ACTION PREPARATIONS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTRONE; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE;

EID: 0029812296     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Baird, D. T., Guevara, A., J. Clin. Endocrinol. Metab. 29, 149 (1969)
2. Baltbur, J. A., Heel. R. C., Drugs 40, 561 (1990)
3. Bekanntmachung von Grundsätzen für die Ordnungsmäßige Durchführung der klinischen Prüfung von Arzneimitteln, Bundesanzeiger 39, 16617 (1987)
4. Bialer, M., Sussan, S., Salach, O. A. et al., J. Pharm. Sci. 84, 1160 (1995)
5. Bolt, H. M., Pharmacol. Ther. 4, 155 (1979)
6. Bush, T. L., Barret-Connor, E., Cowrn, L. D. et al., Circulation 75, 1102 (1987)
7. Christiansen, C., Christensen, M. S., Transbol, I., Lancet I, 459 (1981)
8. Christiansen, C., Lindsay, R., Osteoporosis Int. 1, 7 (1990)
9. Colditz, G. A., Willet, W. C., Stampfer, M. J. et al., N. Engl. J. Med. 316, 1105 (1987)
10. Corson, S. L., Int. J. Fert. 38, 79 (1993)
11. EC Commission, Note for Guidance, Clinical testing of prolonged-action form with special reference to extended release forms. Document III/ 1962/87-EN, Final (1987)
12. EC Commission, Note for Guidance. Investigation of bioavailability and bioequivalence. Document III/54/89-EN, Final (1991)
13. Englund, D. E., Acta Univ. Ups. Nova Acta Regiae Soc. Sci. Diss. 35 (1979)
14. Fink, B. J., Christensen, M. S., Maturitas 3, 289 (1981)
15. Ginsburg, J., Hardiman, P., Okolo, S., Br. Med. J. 302, 1601 (1991)
16. Karlberg, J., Mattsson, L.-Å., Wiklend, I., Acta Obstet, Gynecol. Scand. 74, 367 (1995)
17. Limouzin-Lamothe, M.-A., Mairon, N., Joyce, C. R. B. et al., Am. J. Obstet. Gynecol. 170, 618 (1994)
18. Lindsay, R., Tohme, J. F, Obstet. Gynaecol. 76, 290 (1990)
19. Nichols, K. C., Schenkel, L., Benson, H., Obstet, Gynecol. Survey 39, 230 (1984)
20. Paganini-Hill, A., Ross, R. K., Henderson, B. E., Br. Med. J. 297, 519 (1988)
21. Petitti, D. B., Perlman, J. R., Sidney, S., Obstet, Gynecol. 70, 289 (1987)
22. Powers, M. S., Schenkel, L., Darley, P. et al., Am. J. Obstet. Gynecol. 152, 1099 (1985)
23. Rovati, L. C., Bolis, P. F., Bottiglioni, F. et al., National Congress of the Italian Society for Menopause, Rome (Italy), 26-27 October 1994
24. Scott, R. T., Ross, B., Anderson, C. et al., Obstet. Gynecol. 77, 758 (1991)
25. Setnikar, I., Rovati, L. C., Vens-Cappell, B. et al., Arzneim.-Forsch./Drug Res. 46 (I), 307 (1996)
26. Shah, V. P., Midha, K. K., Dighe, S. et al., J. Pharm. Sci., 81, 309 (1992)
27. Utian, W. H., Am. J. Obstet. Gynecol. 156, 1335 (1987)
28. Whitehead, M. I., Maturitas 1, 87 (1978)
29. Wisowski, D. K., Golden, L., Burke, L., Obstet. Gynecol. 85, 6 (1995)
30. Yen, S. S. C., J. Reprod. Med. 18, 287 (1977)